UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Advances in immunotherapy for hepatocellular carcinoma

Nature reviews. Gastroenterology & hepatology, 2021-08, Vol.18 (8), p.525-543

2021

Volltextzugriff (PDF)

Immunotherapy of Hepatocellular Carcinoma: Facts and Hopes

Clinical cancer research, 2018-04, Vol.24 (7), p.1518-1524

2018

Volltextzugriff (PDF)

Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint

Frontiers in immunology, 2020-05, Vol.11, p.951-951

2020

Volltextzugriff (PDF)

Intratumoural administration and tumour tissue targeting of cancer immunotherapies

Nature reviews. Clinical oncology, 2021-09, Vol.18 (9), p.558-576

2021

Volltextzugriff (PDF)

Immunological impact of cell death signaling driven by radiation on the tumor microenvironment

Nature immunology, 2020-02, Vol.21 (2), p.120-134

2020

Volltextzugriff (PDF)

Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategies

Blood, 2018-01, Vol.131 (1), p.49-57

2018

Volltextzugriff (PDF)

Radiation effects on antitumor immune responses: current perspectives and challenges

Therapeutic Advances in Medical Oncology, 2018-01, Vol.10, p.1758834017742575-1758834017742575

2018

Volltextzugriff (PDF)

Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes

Clinical cancer research, 2019-08, Vol.25 (15), p.4592-4602

2019

Volltextzugriff (PDF)

Revisiting Interleukin-12 as a Cancer Immunotherapy Agent

Clinical cancer research, 2018-06, Vol.24 (12), p.2716-2718

2018

Volltextzugriff (PDF)

Emerging Opportunities and Challenges in Cancer Immunotherapy

Clinical cancer research, 2016-04, Vol.22 (8), p.1845-1855

2016

Volltextzugriff (PDF)

Evolving synergistic combinations of targeted immunotherapies to combat cancer

Nature reviews. Cancer, 2015-08, Vol.15 (8), p.457-472

2015

Volltextzugriff (PDF)

Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma

Nature medicine, 2019-03, Vol.25 (3), p.470-476

2019

Volltextzugriff (PDF)

Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors

Nature medicine, 2020-05, Vol.26 (5), p.688-692

2020

Volltextzugriff (PDF)

Cancer vaccines: the next immunotherapy frontier

Nature cancer, 2022-08, Vol.3 (8), p.911-926

2022

Volltextzugriff (PDF)

Therapeutic vaccines for cancer: an overview of clinical trials

Nature reviews. Clinical oncology, 2014-09, Vol.11 (9), p.509-524

2014

Volltextzugriff (PDF)

Prognostic value of macrophage polarization markers in epithelial neoplasms and melanoma. A systematic review and meta-analysis

Modern pathology, 2020-08, Vol.33 (8), p.1458-1465

2020

Volltextzugriff (PDF)

Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies

Drug resistance updates, 2020-12, Vol.53, p.100718-100718, Article 100718

2020

Volltextzugriff (PDF)

Interleukin-8 in cancer pathogenesis, treatment and follow-up

Cancer treatment reviews, 2017-11, Vol.60, p.24-31

2017

Volltextzugriff (PDF)

Direct Effects of Type I Interferons on Cells of the Immune System

Clinical cancer research, 2011-05, Vol.17 (9), p.2619-2627

2011

Volltextzugriff (PDF)

Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody

Clinical cancer research, 2017-04, Vol.23 (8), p.1929-1936

2017

Volltextzugriff (PDF)

Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis

Clinical cancer research, 2019-08, Vol.25 (15), p.4663-4673

2019

Volltextzugriff (PDF)

Targeting NK-cell checkpoints for cancer immunotherapy

Current opinion in immunology, 2017-04, Vol.45, p.73-81

2017

Volltextzugriff (PDF)

Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs)

Clinical cancer research, 2016-08, Vol.22 (15), p.3924-3936

2016

Volltextzugriff (PDF)

Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer

Cancer discovery, 2017-12, Vol.7 (12), p.1420-1435

2017

Volltextzugriff (PDF)

Anti-CD137 and PD-1/PD-L1 Antibodies En Route toward Clinical Synergy

Clinical cancer research, 2017-09, Vol.23 (18), p.5326-5328

2017

Volltextzugriff (PDF)

1 – 25 von 532

Suche als RSS-Feed

Aktive Filter

ThemaDendritic Cells

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(483)
Mit Volltextzugriff
(465)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(315)
Life Sciences & Biomedicine
(295)
Humans
(188)
Oncology
(150)
Animals
(126)
Immunotherapy
(125)
Immunology
(97)
Mice
(85)
Female
(79)
Tumors
(71)
Cancer
(56)
Neoplasms - Immunology
(50)
Male
(47)
Lymphocytes
(45)
Neoplasms - Therapy
(45)
Immunotherapy - Methods
(35)
Antibodies, Monoclonal - Therapeutic Use
(34)
Biological And Medical Sciences
(34)
Antigens
(31)
Mice, Inbred C57bl
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Advances in immunotherapy for hepatocellular carcinoma

Immunotherapy of Hepatocellular Carcinoma: Facts and Hopes

Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint

Intratumoural administration and tumour tissue targeting of cancer immunotherapies

Immunological impact of cell death signaling driven by radiation on the tumor microenvironment

Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategies

Radiation effects on antitumor immune responses: current perspectives and challenges

Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes

Revisiting Interleukin-12 as a Cancer Immunotherapy Agent

Emerging Opportunities and Challenges in Cancer Immunotherapy

Evolving synergistic combinations of targeted immunotherapies to combat cancer

Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma

Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors

Cancer vaccines: the next immunotherapy frontier

Therapeutic vaccines for cancer: an overview of clinical trials

Prognostic value of macrophage polarization markers in epithelial neoplasms and melanoma. A systematic review and meta-analysis

Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies

Interleukin-8 in cancer pathogenesis, treatment and follow-up

Direct Effects of Type I Interferons on Cells of the Immune System

Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody

Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis

Targeting NK-cell checkpoints for cancer immunotherapy

Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs)

Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer

Anti-CD137 and PD-1/PD-L1 Antibodies En Route toward Clinical Synergy

Aktive Filter

Suchergebnisse filtern